Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B. (Q46931662)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2007

edit

Language	Label	Description	Also known as
English	Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.	scientific article published in January 2007

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

title

Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

main subject

entecavir

1 reference

based on heuristic

inferred from title

lamivudine

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author

Adrian M. Di Bisceglie

series ordinal

6

object named as

Adrian Di Bisceglie

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

David L Veenstra

series ordinal

1

object named as

David L Veenstra

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

Kris V. Kowdley

series ordinal

7

object named as

Kris V Kowdley

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

author name string

Sean D Sullivan

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

Lauren Clarke

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

Uche H Iloeje

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

Eskinder Tafesse

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

Robert G Gish

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

publication date

1 January 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

published in

PharmacoEconomics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

volume

25

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

page(s)

963-977

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

cites work

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200725110-00006

retrieved

21 January 2018

Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200725110-00006

retrieved

21 January 2018

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200725110-00006

retrieved

21 January 2018

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

2 references

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00019053-200725110-00006

retrieved

21 January 2018

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Introduction of lamivudine for the treatment of chronic hepatitis B: expected clinical and economic outcomes based on 4-year clinical trial data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus infection--natural history and clinical consequences

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost of chronic hepatitis B infection in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of liver transplantation for hepatitis B in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling death rates for carriers of hepatitis B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic hepatitis B: a critical appraisal of current approaches to therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The maze of treatments for hepatitis B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of HBV precore/core promoter variants in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of interferon-alpha therapy in the treatment of chronic hepatitis B in Taiwan.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global epidemiology of hepatitis B virus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17960954

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00019053-200725110-00006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

Dimensions Publication ID

1027437282

0 references

PubMed publication ID

17960954

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17960954

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/17960954

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46931662&oldid=2208262989"